Henderson Jeffrey William

CIK 00013240155 companiesDUBLIN, OH

SEC Profile

Transactions

Companies

Filings

CIK

0001324015

Recent Transactions

50 trades

Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-05-01+4,165→ 32,776 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-05-01+5,750→ 5,750 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-04-28$60.34/sh−4,297→ 28,811 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-04-28$60.99/sh−200→ 28,611 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-04-01$64.05/sh−503→ 33,108 total
Award
QUALCOMM INC/DE$QCOM
Common Stock
2025-03-18+2,097→ 10,406 total
Exercise/Conversion
QUALCOMM INC/DE$QCOM
Common Stock
2025-03-09+1,901→ 8,309 total
Exercise/Conversion
QUALCOMM INC/DE$QCOM
Deferred Stock Unit
2025-03-09−1,901.035→ 3,938.365 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-03-03$57.93/sh−1,795→ 36,816 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-03-03$59.12/sh−3,205→ 33,611 total
Purchase
BECTON DICKINSON & CO$BDX
Common Stock
2025-02-10$233.62/sh+1,500→ 8,015 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-03$55.94/sh−1,100→ 42,511 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-03$56.41/sh−3,900→ 38,611 total
Award
BECTON DICKINSON & CO$BDX
Common Stock
2025-01-28+930→ 6,515 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-01-06$50.01/sh−10,000→ 43,611 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-04-25+6,501→ 53,611 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-04-25+8,804→ 8,804 total
Exercise/Conversion
QUALCOMM INC/DE$QCOM
Deferred Stock Unit
2024-03-10−2,056.638→ 5,726.074 total
Exercise/Conversion
QUALCOMM INC/DE$QCOM
Common Stock
2024-03-10+2,056→ 6,408 total
Award
QUALCOMM INC/DE$QCOM
Deferred Stock Unit
2024-03-05+1,624→ 7,772.338 total
Award
BECTON DICKINSON & CO$BDX
Common Stock
2024-01-23+900→ 5,568 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-09-01$1.03/sh−2,000→ 28,866 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-08-04$1.91/sh−2,000→ 30,866 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-07-11$2.69/sh−2,000→ 32,866 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-06-08$17.69/sh−4,994→ 34,866 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-06-08$16.87/sh−2,006→ 39,860 total
Award
FIBROGEN INC$FGEN
Common Stock
2023-06-07+8,289→ 41,866 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2023-06-07+12,666→ 12,666 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2023-05-05+11,371→ 11,371 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2023-05-05+8,065→ 47,110 total
Exercise/Conversion
QUALCOMM INC/DE$QCOM
Deferred Stock Unit
2023-03-10−3,316.611→ 6,004.412 total
Exercise/Conversion
QUALCOMM INC/DE$QCOM
Common Stock
2023-03-10+3,316→ 5,421 total
Disposition to Issuer
QUALCOMM INC/DE$QCOM
Common Stock
2023-03-10$115.19/sh−1,069→ 4,352 total
Award
QUALCOMM INC/DE$QCOM
Deferred Stock Unit
2023-03-08+2,203→ 9,301.048 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2023-03-01$47.71/sh−10,000→ 39,045 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2023-02-28$48.51/sh−10,000→ 49,045 total
Sale
QUALCOMM INC/DE$QCOM
Common Stock
2023-02-23$124.19/sh−2,500→ 2,105 total
Sale
QUALCOMM INC/DE$QCOM
Common Stock
2023-02-22$124.05/sh−2,500→ 4,605 total
Award
BECTON DICKINSON & CO$BDX
Common Stock
2023-01-24+848→ 4,653 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2022-06-16+25,684→ 25,684 total
Award
FIBROGEN INC$FGEN
Common Stock
2022-06-16+15,777→ 33,577 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2022-05-05+6,206→ 59,045 total
Disposition to Issuer
QUALCOMM INC/DE$QCOM
Common Stock
2022-03-12$152.34/sh−1,469→ 7,105 total
Exercise/Conversion
QUALCOMM INC/DE$QCOM
Common Stock
2022-03-12+4,559→ 8,574 total
Exercise/Conversion
QUALCOMM INC/DE$QCOM
Deferred Stock Unit
2022-03-12−4,559.826→ 6,944.491 total
Award
QUALCOMM INC/DE$QCOM
Deferred Stock Unit
2022-03-09+1,774→ 11,485.642 total
Award
BECTON DICKINSON & CO$BDX
Common Stock
2022-01-25+820→ 3,777 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2021-05-26+7,800→ 7,800 total
Award
FIBROGEN INC$FGEN
Common Stock
2021-05-26+4,700→ 17,800 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2021-05-05+5,230→ 52,839 total

Companies

Recent Filings

Address

7000 CARDINAL PLACE

DUBLIN, OH, 43017

View on SEC.gov